Certain populations to receive Paxlovid free through 2024, under new agreement
By
Kristen Fischer
Oct 17, 2023
Paxlovid, an oral drug that treats COVID-19, will begin to enter the commercial market starting next month. At the same time, the US federal government is making sure that the country has enough supply,...
It’s official: Omicron causes less severe COVID-19 illness than prior variants, CDC study finds
By
Alicia Lasek
Jan 26, 2022
The SARS-CoV-2 omicron variant is much less likely to cause severe illness and death than its predecessors, according to a new analysis of U.S. data from December 2020 through mid-January 2022.
CDC: Prepare for rebound in TB cases post-pandemic
By
Alicia Lasek
Mar 21, 2022
A 20% decline in tuberculosis cases in 2020 may be followed by an uptick once the COVID-19 pandemic wanes, according to CDC investigators. Clinicians should be prepared to detect cases and control spread,...
Blood thinner reduces acute-care stays of COVID-19 patients: study
By
Alicia Lasek
Aug 06, 2021
Moderately ill hospitalized COVID-19 patients who receive a full dose of heparin have less need for mechanical ventilation, and improved chances of leaving the hospital, a new trial has found.
Study: When community-onset SARS-CoV-2 went up, so did cases that started in hospitals
By
Kristen Fischer
Aug 29, 2023
Rates of people contracting SARS-CoV-2 in the hospital were similar to other hospital-acquired infections. But when the number of infections that began in the community was higher, there was an increase...
Report: COVID-19 linked to higher dementia risk in older adults
By
Kristen Fischer
Feb 12, 2024
A new study found a link between having COVID-19 and a higher risk for dementia in people over the age of 60.
Older adults, immunocompromised net biggest benefits from COVID-19 boosters, model shows
By
Kristen Fischer
Mar 07, 2024
A new model estimates that people over 65 or those who are immunocompromised benefit the most from COVID-19 booster shots.
The dissent: CDC adviser fears loss of vaccine confidence
By
Alicia Lasek
Dec 07, 2020
Although the first COVID-19 vaccines may be safe, symptoms or death from unrelated causes in the vulnerable LTC population may be incorrectly associated with immunization, one adviser says.
COVID-19 connected to dementia-like disability, multiple studies find
By
Alicia Lasek
Jul 27, 2021
A bout with COVID-19 can cause dementia-like brain changes and related functional decline, especially for seniors and in people who lose their sense of smell, researchers are finding.
Feds uncover coronavirus’s heavy toll on assisted living
By
Alicia Lasek
Nov 20, 2020
As of Oct. 15, 22% of assisted living communities in 39 states reported cases of COVID-19 among residents and staff members. Rates ranged widely, from 1.3% of communities in Iowa to 93% of Connecticut...